W. R. Buckett

1.8k total citations
58 papers, 1.4k citations indexed

About

W. R. Buckett is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, W. R. Buckett has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in W. R. Buckett's work include Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (19 papers) and Receptor Mechanisms and Signaling (16 papers). W. R. Buckett is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (19 papers) and Receptor Mechanisms and Signaling (16 papers). W. R. Buckett collaborates with scholars based in United Kingdom, France and Denmark. W. R. Buckett's co-authors include David J. Heal, Graham P. Luscombe, Sharon C. Cheetham, M.R. Prow, P. C. Thomas, Keith F. Martin, Jean Viggers, Nigel K.H. Slater, D.J. Heal and Paul J. Schechter and has published in prestigious journals such as Brain Research, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

W. R. Buckett

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. R. Buckett United Kingdom 22 744 467 428 295 158 58 1.4k
Harold D. Snoddy United States 25 1.1k 1.5× 594 1.3× 298 0.7× 312 1.1× 150 0.9× 82 2.0k
Charles Saller United States 22 913 1.2× 486 1.0× 224 0.5× 335 1.1× 182 1.2× 36 1.7k
Kornélia Tekes Hungary 26 468 0.6× 461 1.0× 467 1.1× 198 0.7× 143 0.9× 129 1.8k
H. H. Keller Switzerland 21 1.1k 1.5× 594 1.3× 215 0.5× 235 0.8× 87 0.6× 35 2.0k
F Hoffmeister Germany 18 616 0.8× 490 1.0× 153 0.4× 233 0.8× 191 1.2× 68 1.5k
R.P. Maickel United States 22 780 1.0× 468 1.0× 169 0.4× 410 1.4× 120 0.8× 78 1.8k
Susan K. Hemrick-Luecke United States 22 876 1.2× 442 0.9× 276 0.6× 332 1.1× 41 0.3× 70 1.6k
Jewell W. Sloan United States 17 942 1.3× 400 0.9× 325 0.8× 313 1.1× 60 0.4× 55 1.7k
S.Z. Langer France 20 1.5k 2.0× 1.1k 2.5× 238 0.6× 270 0.9× 86 0.5× 47 2.1k
David J. Brunswick United States 27 857 1.2× 607 1.3× 418 1.0× 158 0.5× 87 0.6× 70 1.9k

Countries citing papers authored by W. R. Buckett

Since Specialization
Citations

This map shows the geographic impact of W. R. Buckett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. R. Buckett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. R. Buckett more than expected).

Fields of papers citing papers by W. R. Buckett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. R. Buckett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. R. Buckett. The network helps show where W. R. Buckett may publish in the future.

Co-authorship network of co-authors of W. R. Buckett

This figure shows the co-authorship network connecting the top 25 collaborators of W. R. Buckett. A scholar is included among the top collaborators of W. R. Buckett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. R. Buckett. W. R. Buckett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heal, D.J., Sharon C. Cheetham, M.R. Prow, Keith F. Martin, & W. R. Buckett. (1998). A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents. British Journal of Pharmacology. 125(2). 301–308. 87 indexed citations
2.
Heal, David J., et al.. (1995). Receptor binding and functional evidence suggest that postsynaptic α2-adrenoceptors in rat brain are of the α2D subtype. European Journal of Pharmacology. 277(2-3). 215–221. 16 indexed citations
3.
Heal, D.J., Carole Czudek, & W. R. Buckett. (1994). Common profile of D1 receptor antagonists and atypical antipstchotic drugs revealed by analysis of dopamine turnover. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 18(4). 803–821. 8 indexed citations
4.
Cheetham, Sharon C., Jean Viggers, Nigel K.H. Slater, David J. Heal, & W. R. Buckett. (1993). [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology. 32(8). 737–743. 109 indexed citations
5.
Heal, David J., et al.. (1992). A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride. Psychopharmacology. 107(4). 497–502. 11 indexed citations
6.
7.
8.
Heal, David J., M.R. Prow, & W. R. Buckett. (1991). Determination of the role of noradrenergic and 5‐hydroxytryptaminergic neurones in postsynaptic α2‐adrenoceptor desensitization by desipramine and ECS. British Journal of Pharmacology. 103(4). 1865–1870. 14 indexed citations
9.
Sanghera, Manjit K., Francesco Crespi, Keith F. Martin, et al.. (1990). Biochemical and in vivo voltammetric evidence for differences in striatal dopamine levels in inbred strains of mice. Neuroscience. 39(3). 649–656. 12 indexed citations
10.
11.
Heal, David J., et al.. (1989). Clonidine produces mydriasis in conscious mice by activating central α2-adrenoceptors. European Journal of Pharmacology. 170(1-2). 11–18. 14 indexed citations
12.
Heal, David J., et al.. (1989). Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β1 but Not β2‐Adrenoceptors in Rat Cortex. Journal of Neurochemistry. 53(4). 1019–1025. 50 indexed citations
13.
Heal, David J., et al.. (1989). Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic α2-adrenoceptors in the brain. European Journal of Pharmacology. 170(1-2). 19–28. 32 indexed citations
14.
Heal, David J., et al.. (1989). Sex‐related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock. British Journal of Pharmacology. 97(1). 111–118. 20 indexed citations
15.
Buckett, W. R., et al.. (1984). Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites. European Journal of Pharmacology. 105(3-4). 257–263. 21 indexed citations
16.
Buckett, W. R.. (1981). Pharmacological studies on stimulation-produced analgesia in mice. European Journal of Pharmacology. 69(3). 281–290. 25 indexed citations
17.
Buckett, W. R.. (1979). Peripheral stimulation in mice induces short-duration analgesia preventable by naloxone. European Journal of Pharmacology. 58(2). 169–178. 37 indexed citations
18.
Buckett, W. R., Nicola Crossland, R. H. B. GALT, et al.. (1977). The xanthene-spiropiperidines: a new group of centrally-active drugs [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(1). 146P–147P. 1 indexed citations
19.
Buckett, W. R.. (1967). Laboratory Testing of New Drugs for Morphine‐Like Drug Dependence. British Journal of Addiction to Alcohol & Other Drugs. 62(3-4). 387–390. 2 indexed citations
20.
Buckett, W. R., et al.. (1964). Antibacterial properties of 5-nitro-2-furylglyoxylidene derivatives. Journal of Pharmacy and Pharmacology. 16(10). 663–669. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harold D. Snoddy Breakdown of academic impact, for papers by Charles Saller Breakdown of academic impact, for papers by Kornélia Tekes Breakdown of academic impact, for papers by H. H. Keller Breakdown of academic impact, for papers by F Hoffmeister Breakdown of academic impact, for papers by R.P. Maickel Breakdown of academic impact, for papers by Susan K. Hemrick-Luecke Breakdown of academic impact, for papers by Jewell W. Sloan Breakdown of academic impact, for papers by S.Z. Langer Breakdown of academic impact, for papers by David J. Brunswick
Rankless by CCL
2026